Research
Hormonal
Targeted antiobesity medications (AOM) have demonstrated significant weight loss and improved quality of life in patients with specific genetic obesity disorders.
Practitioners should consider targeted AOMs for patients with genetic obesity disorders to improve weight management and quality of life.
StrongSupportsmedium confidence
Targeted AOMs have demonstrated significant weight loss, reduced obesity-related comorbidities, and improved hyperphagia and quality of life in patients with specific genetic obesity disorders.
Why this rating
The claim is based on findings from targeted AOMs in specific genetic obesity disorders.
Source
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway
Mila S. Welling et al. · Endocrine Reviews · 2025
reviewCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →